Amanta Healthcar

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
147.45
-0.8 (-0.54%)
BSENSE

Jun 18

BSE+NSE Vol: 9.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

147.45152.00

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

9.92 k (-95.86%) Volume

Shareholding (Mar 2026)

FII

0.85%

Held by 4 FIIs

DII

12.88%

Held by 3 DIIs

Promoter

63.72%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 14.23%

  • Poor long term growth as Net Sales has grown by an annual rate of -2.00% and Operating profit at 9.30% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 2.51 times
2

Flat results in Mar 26

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 583 Cr ()

stock-summary
P/E

35.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.61

Revenue and Profits:
Net Sales:
77 Cr
(Quarterly Results - Mar 2026)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
51.46%
0%
51.46%
6 Months
34.23%
0%
34.23%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Are Amanta Healthcare Ltd latest results good or bad?

Amanta Healthcare Ltd's latest financial results for Q4 FY26 reflect a complex operational landscape. The company reported net sales of ₹76.99 crores, marking a sequential increase of 3.36% from the previous quarter and a year-on-year growth of 6.84%. This indicates some positive momentum in revenue generation, potentially suggesting improved market penetration or product portfolio expansion. However, the operational efficiency metrics reveal challenges. The net profit for the quarter rose to ₹5.53 crores, a 19.44% increase from Q3 FY26, driven by lower interest costs and a slight uptick in other income. Despite this, the net profit remains below the previous year's figure, highlighting ongoing profitability concerns. The operating margin contracted to 19.42%, down from 20.62% in the prior quarter, indicating significant cost pressures or pricing challenges that may affect the company's ability to maintain...

Read More
Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure

Amanta Healthcare Ltd Reports Flat Quarterly Performance Amid Margin Pressure

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record net sales and a strong operating profit to interest ratio, the company’s operating profit margin contracted significantly, prompting a downgrade in its Mojo Grade from Hold to Sell.

Read More

When is the next results date for Amanta Healthcare Ltd?

The next results date for Amanta Healthcare Ltd is scheduled for 19 May 2026....

Read More
Announcements stock-summary

Intimation For Commissioning Of Solar Power Plant For Captive Consumption

30-May-2026 | Source : BSE

Intimation for commissioning of solar power plant for captive consumption

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026

Statement Of Deviation Or Variation In Utilization Of Funds If Any.

29-May-2026 | Source : BSE

statement of deviation or variation of funds if any

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.00%
EBIT Growth (5y)
9.30%
EBIT to Interest (avg)
1.53
Debt to EBITDA (avg)
3.54
Net Debt to Equity (avg)
1.99
Sales to Capital Employed (avg)
0.74
Tax Ratio
29.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.72%
ROCE (avg)
13.00%
ROE (avg)
8.18%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
34
Price to Book Value
2.61
EV to EBIT
17.69
EV to EBITDA
12.15
EV to Capital Employed
1.96
EV to Sales
2.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.06%
ROE (Latest)
7.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (5.09%)

FIIs

Held by 4 FIIs (0.85%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.25%)

Highest Public shareholder

Bandhan Small Cap Fund (5.09%)

Individual Investors Holdings

16.0%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 3.36% vs 5.08% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 19.44% vs 282.64% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76.99",
          "val2": "74.49",
          "chgp": "3.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.95",
          "val2": "15.36",
          "chgp": "-2.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.25",
          "val2": "5.06",
          "chgp": "-16.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.53",
          "val2": "4.63",
          "chgp": "19.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.42%",
          "val2": "20.62%",
          "chgp": "-1.20%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Amanta Healthcar"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Amanta Healthcar"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 41.71% vs 189.26% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "287.68",
          "val2": "274.71",
          "chgp": "4.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.86",
          "val2": "59.67",
          "chgp": "0.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.75",
          "val2": "27.95",
          "chgp": "-25.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "14.88",
          "val2": "10.50",
          "chgp": "41.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.81%",
          "val2": "21.72%",
          "chgp": "-0.91%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
76.99
74.49
3.36%
Operating Profit (PBDIT) excl Other Income
14.95
15.36
-2.67%
Interest
4.25
5.06
-16.01%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.53
4.63
19.44%
Operating Profit Margin (Excl OI)
19.42%
20.62%
-1.20%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 3.36% vs 5.08% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 19.44% vs 282.64% in Dec 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
287.68
274.71
4.72%
Operating Profit (PBDIT) excl Other Income
59.86
59.67
0.32%
Interest
20.75
27.95
-25.76%
Exceptional Items
-2.63
0.00
Standalone Net Profit
14.88
10.50
41.71%
Operating Profit Margin (Excl OI)
20.81%
21.72%
-0.91%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 41.71% vs 189.26% in Mar 2025

All Annual Resultsstock-summary
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."